Semaglutide is a GLP-1 receptor agonist licensed in the UK for type 2 diabetes mellitus, not directly linked to menstrual irregularities in clinical trials
Particularly for: (Source: Sikiric et al., World Journal of Gastroenterology, 2016) Studies done on animals report increased peripheral nerve regeneration
26 In a comprehensive study conducted in China, the prevalence of DN among diabetes patients was 37%
GLP-1 signals the brain to reduce hunger, slows the rate at which the stomach empties, and helps regulate blood sugar
Realistic expectations: 5-10 pounds lean muscle (drug-free this would take 1-2 years) Body fat reduced 2-4% Strength up 20-30% Overall appearance transformed Month 6-12: Peak results and beyond Physical changes: 8-15 pounds lean muscle (cumulative, depends heavily on starting point) Strength plateaus at new higher baseline Body composition optimized Continued slow improvements What you'll notice: You've reached a new baseline Further gains slow down but you maintain easily The "enhanced" look is permanent if you continue basic protocol Can reduce peptide frequency to maintenance doses What photos show: Maximum transformation
What hidden costs should I expect with GLP-1 treatment programs
